Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1981 Oct;44(4):553–560. doi: 10.1038/bjc.1981.225

Tumour spectrum in the FAMMM syndrome.

H T Lynch, R M Fusaro, J Pester, J A Oosterhuis, L N Went, P Rumke, H Neering, J F Lynch
PMCID: PMC2010801  PMID: 7295511

Abstract

The Familial Atypical Multiple Mole-Melanoma Syndrome (FAMMM) is characterized by an autosomal dominantly inherited susceptibility to multiple atypical naevi. Patients with this hereditary phenotype show a strong susceptibility to cutaneous malignant melanoma (CMM). Our investigation of an extended Dutch kindred showing the FAMMM phenotype revealed a proband with bilateral intraocular malignant melanoma (IOM) and multiple CMM. The family revealed an array of tumours which included carcinoma of the lung, skin, larynx, and breast in addition to CMM and IOM, which were transmitted vertically through 3 generations. There was male-to-male transmission, and the number of affected males and females was about the same, which was consistent with an autosomal dominant inheritance. Thus the FAMMM syndrome not only indicates a potential for CMM, but a susceptibility to other systemic cancers as well. These observations, though limited to a single kindred, merit a painstaking evaluation of cancer of all anatomical sites in other kindreds showing the FAMMM syndrome. Such studies could yield clues to cancer aetiology, pathogenesis, and control.

Full text

PDF
553

Images in this article

556Fig. 2
on p.556
556Fig. 3
on p.556
557Fig. 4
on p.557

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bellet R. E., Shields J. A., Soll D. B., Bernardino E. A. Primary choroidal and cutaneous melanomas occurring in a patient with the B-K mole syndrome phenotype. Am J Ophthalmol. 1980 Apr;89(4):567–570. doi: 10.1016/0002-9394(80)90068-9. [DOI] [PubMed] [Google Scholar]
  2. Bondi E. E., Clark W. H., Jr, Elder D., Guerry D., 4th, Greene M. H. Topical chemotherapy of dysplastic melanocytic nevi with 5% fluorouracil. Arch Dermatol. 1981 Feb;117(2):89–92. [PubMed] [Google Scholar]
  3. CAWLEY E. P., KRUSE W. T., PINKUS H. K. Genetic aspects of malignant melanoma. AMA Arch Derm Syphilol. 1952 Apr;65(4):440–450. doi: 10.1001/archderm.1952.01530230064006. [DOI] [PubMed] [Google Scholar]
  4. Clark W. H., Jr, Reimer R. R., Greene M., Ainsworth A. M., Mastrangelo M. J. Origin of familial malignant melanomas from heritable melanocytic lesions. 'The B-K mole syndrome'. Arch Dermatol. 1978 May;114(5):732–738. [PubMed] [Google Scholar]
  5. Elder D. E., Goldman L. I., Goldman S. C., Greene M. H., Clark W. H., Jr Dysplastic nevus syndrome: a phenotypic association of sporadic cutaneous melanoma. Cancer. 1980 Oct 15;46(8):1787–1794. doi: 10.1002/1097-0142(19801015)46:8<1787::aid-cncr2820460816>3.0.co;2-s. [DOI] [PubMed] [Google Scholar]
  6. Frichot B. C., 3rd, Lynch H. T., Guirgis H. A., Harris R. E., Lynch J. F. New cutaneous phenotype in familial malignant melanoma. Lancet. 1977 Apr 16;1(8016):864–865. doi: 10.1016/s0140-6736(77)92822-7. [DOI] [PubMed] [Google Scholar]
  7. Grimstvedt M. Familiaer forekomst av maligne melanomer. Tidsskr Nor Laegeforen. 1969 Dec 15;89(24):1900–1902. [PubMed] [Google Scholar]
  8. Lynch H. T., Frichot B. C., 3rd, Fisher J., Smith J. L., Jr, Lynch J. F. Spontaneous regression of metastatic malignant melanoma in 2 sibs with xeroderma pigmentosum. J Med Genet. 1978 Oct;15(5):357–362. doi: 10.1136/jmg.15.5.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Lynch H. T., Frichot B. C., 3rd, Lynch J. F. Familial atypical multiple mole-melanoma syndrome. J Med Genet. 1978 Oct;15(5):352–356. doi: 10.1136/jmg.15.5.352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Lynch H. T., Frichot B. C., Lynch P., Lynch J., Gurigis H. A. Family studies of malignant melanoma and associated cancer. Surg Gynecol Obstet. 1975 Oct;141(4):517–522. [PubMed] [Google Scholar]
  11. Lynch H. T., Fusaro R. M., Pester J., Lynch J. F. Familial atypical multiple mole melanoma (FAMMM) syndrome: genetic heterogeneity and malignant melanoma. Br J Cancer. 1980 Jul;42(1):58–70. doi: 10.1038/bjc.1980.203. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Lynch H. T. Genetics, etiology, and human cancer. Prev Med. 1980 Mar;9(2):231–243. doi: 10.1016/0091-7435(80)90081-x. [DOI] [PubMed] [Google Scholar]
  13. Lynch H. T., Krush A. J. Heredity and malignant melanoma: implications for early cancer detection. Can Med Assoc J. 1968 Jul 6;99(1):17–21. [PMC free article] [PubMed] [Google Scholar]
  14. Oxenhandler R. W., Adelstein E. H., Haigh J. P., Hook R. R., Jr, Clark W. H., Jr Malignant melanoma in the Sinclair miniature swine: an autopsy study of 60 cases. Am J Pathol. 1979 Sep;96(3):707–720. [PMC free article] [PubMed] [Google Scholar]
  15. Reimer R. R., Clark W. H., Jr, Greene M. H., Ainsworth A. M., Fraumeni J. F., Jr Precursor lesions in familial melanoma. A new genetic preneoplastic syndrome. JAMA. 1978 Feb 20;239(8):744–746. [PubMed] [Google Scholar]
  16. Rodríguez-Sains R. S. Are concurrent or subsequent malignant melanomas in the skin and eye related or coincidental? J Dermatol Surg Oncol. 1980 Nov;6(11):915–918. doi: 10.1111/j.1524-4725.1980.tb01002.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES